v3.26.1
CONDENSED INTERIM STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows from Operating Activities:    
Net Loss $ (3,935,155) $ (4,395,472)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:    
Share-Based Compensation 458,824 657,814
Share-Based Payments to Vendors 141,999 196,260
(Increase)/Decrease in:    
Other Receivable (46,890) 10,919
Prepaid Expenses (148,066) 46,601
Accounts Payable and Accrued Expenses 411,803 (238,195)
Net Cash Used in Operating Activities (3,117,485) (3,722,073)
Cash Flows from Financing Activities:    
Proceeds from issuance of common stock in connection with equity line of credit purchase agreement, net of issuance costs 3,945,913 610,262
Proceeds from 2026 April Registered Direct Offering, net of issuance costs 2,271,858  
Proceeds from 2025 March Registered Direct Offering, net of issuance costs   889,420
Proceeds from 2025 January Registered Direct Offering, net of issuance costs   2,099,253
Proceeds from 2025 Warrant Exercise, net of issuance costs   2,480,553
Net Cash Provided by Financing Activities 6,217,771 6,079,488
Net Increase in Cash 3,100,286 2,357,415
Cash at Beginning of Period 7,556,100 3,706,713
Cash at End of Period $ 10,656,386 6,064,128
SUPPLEMENTAL DISCLOSURE OF NON-CASH OPERATING ACTIVITIES    
Share-Based Compensation to settle accrued compensation (Note 5)   413,120
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES    
2025 Equity Line of Credit Purchase Agreement costs (Commitment shares) (Note 4)   360,000
2025 Warrant Inducement Financing cost (Note 4)   4,636,869
2025 January Registered Direct Offering costs (Note 4)   85,419
2025 March Registered Direct Offering costs (Note 4)   $ 56,163